Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marija Čeh"'
Autor:
Irena Preložnik Zupan, Tadej Pajič, Marjana Glaser, Tatjana Grmek Zemljič, Mateja Grat, Nataša Fikfak, Irena Bricman, Marija Čeh, Vlasta Petric, Milica Skamagkoulis
Publikováno v:
Zdravniški Vestnik, Vol 81, Iss SUPL II (2012)
Background: Chronic myeloid leukemia (CML) is a malignant myeloproliferative disorder of hematopoietic stem cells. It is the first malignancy with a known specific chromosomal abnormality, the Philadelphia (Ph) chromosome t(9;22) (q34;q11), which has
Externí odkaz:
https://doaj.org/article/f93cd3e29ca74c11a752947b092a3909
Autor:
Marija Čeh
Publikováno v:
Zdravniški Vestnik, Vol 81, Iss SUPL II (2012)
Background: Methotrexate has gained wide acceptance due to its efficacy in a variety of inflammatory rheumatological disorders. However, it has the potential to cause serious, life-threatening complications. Risk-factors that are important in the dev
Externí odkaz:
https://doaj.org/article/278cd318711a4ead8e73d32bb501eb97
Publikováno v:
Zdravniški Vestnik, Vol 80, Iss 5 (2011)
Background: Chronic myeloid leukaemia is a clonal myeloproliferative disorder of myeloid progenitor cells. The availability of moleculartargeted therapy with tyrosine kinase inhibitors has changed the course and treatment for patients with chronic my
Externí odkaz:
https://doaj.org/article/82de25c931404f7485d6f825d5066a83
Autor:
Jernej Mlakar, Irena Preložnik Zupan, Eva Kralj, Jurij Trontelj, Lara Lusa, Mateja Grat, Nataša Fikfak, Irena Umek Bricman, Marija Čeh, Vlasta Petric, Tadej Pajič
Publikováno v:
Zdravniški Vestnik, Vol 80, Iss 3 (2011)
Background: In past ten years imatinib (IM) has greatly improved the prognosis of patients with chronic myeloid leukemia (CML). However, 30 % of patients still fail to achieve treatment goals or cannot maintain them later. In the last three year
Externí odkaz:
https://doaj.org/article/d750e7ed676641f294b8d37463a865f2
Autor:
Irena Preložnik Zupan, Tadej Pajič, Marjana Glaser, Tatjana Grmek Zemljič, Mateja Grat, Nataša Fikfak, Irena Bricman, Marija Čeh, Vlasta Petric
Publikováno v:
Zdravniški Vestnik, Vol 77, Iss SUPPI (2008)
BACKGROUND Chronic myeloid leukaemia (CML) is a rare clonal neoplastic disease of hematopoieticstem cells. Epidemiology data of CML patients in Slovenia are presented. METHODS Data about all new patients with CML in the period from 2002 to 2007 were
Externí odkaz:
https://doaj.org/article/d70bedfd8ce64d4992a30d77bc050da0
Autor:
Marija Čeh
Publikováno v:
Zdravniški Vestnik, Vol 77, Iss SUPPI (2008)
BACKGROUND Pure red cell aplasia (PRCA) is a rare condition of severe anemia characterized by anabsence of erythroid precursor in the bone marrow, severe reticulocytopenia and normalplatelet and leukocyte count. This condition appears as an acquired
Externí odkaz:
https://doaj.org/article/04225ec240d448e3b298f61745831c0b
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 12, Iss 1 (2019)
Background To stimulate use of generic medicines a combination of supply and demand side mechanisms are employed in the Latvian reimbursement system. It is reported that patients have high out-of-pocket pharmaceutical spending and that they overpay b
Externí odkaz:
https://doaj.org/article/345b7c2f6f214e7f9249721956ef830c
Autor:
Marija Cehner
Publikováno v:
Obzornik zdravstvene nege, Vol 10, Iss 2 (1976)
Externí odkaz:
https://doaj.org/article/2de071108b974a9696ccb5c6b9a4f064